IMPACT OF PRETRETMENT LEUKOCYTOSIS ON PROGNOSIS IN LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMORADIOTHERAPY

被引：0
|
作者：
Topkan, Erkan [1 ]
Parlak, Cem [1 ]
Guler, Ozan C. [1 ]
Pehlivan, Berrin [2 ]
Selek, Ugur [3 ]
机构：
[1] Baskent Univ, Fac Med, Dept Radiat Oncol, Ankara, Turkey
[2] Medstar Antalya Hosp, Dept Radiat Oncol, Antalya, Turkey
[3] Univ Texas MD Anderson, Radiat Oncol Ctr, Amer Hosp, Dept Radiat Oncol, Istanbul, Turkey
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
locally advanced non-small cell lung cancer; Concurrent chemoradiotherapy; pretreatment white blood cell count;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO25.08
引用
收藏
页码：S412 / S412
页数：1
相关论文
共 50 条
  • [31] Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy
    Chen, Kuifei
    Li, Shuling
    Chen, Meng
    Jin, Zhicheng
    Sun, Xuefeng
    Zhou, Suna
    Yang, Haihua
    BMC CANCER, 2024, 24 (01)
  • [32] Radiogenomics models for predicting prognosis in locally advanced non-small cell lung cancer patients undergoing definitive chemoradiotherapy
    Song, Xiaoyu
    Li, Li
    Yu, Qingxi
    Liu, Ning
    Zhu, Shouhui
    Yuan, Shuanghu
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (08)
  • [33] Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer
    Ito, Hitoshi
    Matsuo, Yukinori
    Ohtsu, Shuji
    Nishimura, Takashi
    Terada, Yasuji
    Sakamoto, Takashi
    Mizowaki, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (02) : 274 - 281
  • [34] Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer
    Hitoshi Ito
    Yukinori Matsuo
    Shuji Ohtsu
    Takashi Nishimura
    Yasuji Terada
    Takashi Sakamoto
    Takashi Mizowaki
    International Journal of Clinical Oncology, 2020, 25 : 274 - 281
  • [35] Concurrent chemoradiotherapy in non-small cell lung cancer
    O'Rourke, Noelle
    Roque i Figuls, Marta
    Farre Bernado, Nuria
    Macbeth, Fergus
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (06):
  • [36] EFFICACY OF CONCURRENT CHEMORADIOTHERAPY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER
    Almodovar, M.
    Ramos, H.
    Mota, P.
    Martins, V.
    Pereira, P.
    LUNG CANCER, 2011, 71 : S42 - S43
  • [37] Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer
    W.-G. Lan
    Y.-Z. Hao
    D.-H. Xu
    P. Wang
    Y.-L. Zhou
    L.-B. Ma
    Clinical and Translational Oncology, 2016, 18 : 375 - 380
  • [38] Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer
    Lan, W-G.
    Hao, Y-Z.
    Xu, D-H.
    Wang, P.
    Zhou, Y-L.
    Ma, L-B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (04): : 375 - 380
  • [39] Neoadjuvant Radiotherapy/Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
    Yalman, Deniz
    BALKAN MEDICAL JOURNAL, 2015, 32 (01) : 1 - 7
  • [40] Audit of chemoradiotherapy (CRT) in locally advanced non-small cell lung cancer
    Wong, S. -L.
    Morley, T.
    Meng, K.
    Mahmood, W.
    Forster, M.
    Mendes, R.
    LUNG CANCER, 2015, 87 : S53 - S53
12345